CAN:s bibliotek
 
Problems of drug dependence, 2002 : proceedings of the 64th Annual Scientific Meeting : the College on Problems of Drug Dependence, Inc.
Komihåglistan är tom
Vis
Institutionsnamn
  • College on Problems of Drug Dependence. Scientific Meeting (64 : 2002 : Quebec)
Titel och upphov
  • Problems of drug dependence, 2002 : proceedings of the 64th Annual Scientific Meeting : the College on Problems of Drug Dependence, Inc.
Utgivning, distribution etc.
  • National Institute on Drug Abuse, Bethesda, Md : 2003
Fysisk beskrivning
  • 265 s : ill.
Serietitel - biuppslagsform
  • NIDA research monograph series ; 183
  • NIH publication ; 03- 5339
Anmärkning: Allmän
  • E-bok
Anmärkning: Innehållsbeskrivning, sammanfattning
  • Is dopamine the answer? Evidence for the importance of other systems in the reinforcing/neurochemical effects of psychostimulants. Substance abuse, immunomodulation and infections. What are they thinking? The mediating rolearental cognitions in the parenting processes of drug-dependent mothers and fathers. Drug reward in humans: what does dopamine do? medical consequences of problems of drug dependence. Understanding the abuse-relevant effects of drugs: studies by young investigatorng the abuse-relevant effects of drugs: studies by young investigators. Prescription drug abuse: what do we know? Cocaine addiction: to the amygdala and beyond. Longitudinal studies of pathways to drug abuse: current status, emerging findings, and implications for prevention. Drugs and crime. Violence exposure and substance abuse. Neuropeptidergic responses to psychostimulant drugs of abuse: strategies for drug development. The new thing: applying information technologies to drug abuse prevention and treatment. French experience with Buprenorphine. Drug choice: what we know and what we need to know. Biological evaluation of compounds for their psychical dependence potential and abuse liability. XXVI. Drug Evaluation Committee e college on problems of drug dependence (2002). Evaluation of new compounds for opioid activity (2002). Dependence studies of new compounds in the rhesus monkey, rat and mouse (2002). Progress report from the testing program for stimulant and depressant drugs (2002). NIDA medications development and resources for medical chemists targeting biogenic amine transporters. (From the table of contents)
Term
Indexterm - Okontrollerad
Personnamn
Institutionsnamn
  • National Institute on Drug Abuse 
*000      am a        a
*00113994
*007cr |||||||||||
*008070120s2003||||xxu||||es|||||||||1|eng||
*1101 $aCollege on Problems of Drug Dependence. Scientific Meeting (64 : 2002 : Quebec)
*24510$aProblems of drug dependence, 2002 :$bproceedings of the 64th Annual Scientific Meeting : the College on Problems of Drug Dependence, Inc.
*260  $aBethesda, Md :$bNational Institute on Drug Abuse,$c2003
*300  $a265 s :$bill.
*440  $aNIDA research monograph series ;$v183
*440  $aNIH publication ;$v03- 5339
*500  $aE-bok
*520  $aIs dopamine the answer? Evidence for the importance of other systems in the reinforcing/neurochemical effects of psychostimulants. Substance abuse, immunomodulation and infections. What are they thinking? The mediating rolearental cognitions in the parenting processes of drug-dependent mothers and fathers. Drug reward in humans: what does dopamine do? medical consequences of problems of drug dependence. Understanding the abuse-relevant effects of drugs: studies by young investigatorng the abuse-relevant effects of drugs: studies by young investigators. Prescription drug abuse: what do we know? Cocaine addiction: to the amygdala and beyond. Longitudinal studies of pathways to drug abuse: current status, emerging findings, and implications for prevention. Drugs and crime. Violence exposure and substance abuse. Neuropeptidergic responses to psychostimulant drugs of abuse: strategies for drug development. The new thing: applying information technologies to drug abuse prevention and treatment. French experience with Buprenorphine. Drug choice: what we know and what we need to know. Biological evaluation of compounds for their psychical dependence potential and abuse liability. XXVI. Drug Evaluation Committee e college on problems of drug dependence (2002). Evaluation of new compounds for opioid activity (2002). Dependence studies of new compounds in the rhesus monkey, rat and mouse (2002). Progress report from the testing program for stimulant and depressant drugs (2002). NIDA medications development and resources for medical chemists targeting biogenic amine transporters. (From the table of contents)
*650 4$aSubstance-related disorders
*650 4$aDopamine
*650 4$aParents
*650 4$aCocaine-related disorders
*650 4$aPrevention
*650 4$aBuprenorphine
*650 4$aViolence
*650 4$aCrime
*650 4$aReward
*653  $aNarkotikamissbruk
*653  $aDopamin
*653  $aFöräldrar
*653  $aMedicinska aspekter
*653  $aVåld
*653  $aKriminalitet
*653  $aBelöning
*653  $aBuprenorfin
*653  $aKokainmissbruk
*7001 $aDewey, William L.$eco-ed.
*7001 $aHarris, Louis S.$eco-ed.
*7101 $aNational Institute on Drug Abuse$0124050
*85640$uhttps://hdl.handle.net/2027/mdp.39015056523247
^
Det finns inga omdömen till denna titeln.
Klicka här för att vara den första som skriver ett omdöme.
Vis
Sänd till